                               SEQUENCE LISTING                               

<110> UNIVERSITY OF WASHINGTON

<120> COMPOSITIONS AND METHODS FOR THE TREATMENT OF
      RESPIRATORY DISORDERS

<130> 034186-001142-PCT

<140>
<141>

<150> 60/931,136
<151> 2007-05-21

<160> 5                             

<170> PatentIn Ver. 3.3

<210> 1
<211> 21
<212> RNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 1
gggacccucc uccggagcca g                                           21    


<210> 2
<211> 21
<212> RNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 2
ggcuccggag gagggucccc g                                           21    


<210> 3
<211> 21
<212> RNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 3
ggucuucuca cacaucggcu u                                           21    


<210> 4
<211> 21
<212> RNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<400> 4
gccgaugugu gagaagaccu u                                           21    


<210> 5
<211> 23
<212> DNA
<213> Artificial Sequence

<220> 
<223> Description of Artificial Sequence: Synthetic
      oligonucleotide

<220> 
<221> modified_base
<222> (3)..(21)
<223> a, c, g, t, unknown or other

<400> 5
aannnnnnnn nnnnnnnnnn ntt                                         23    


